🔎 Trials Near Me

Utama › Kanser Kolon › Massachusetts › Boston

Kajian klinikal Kanser Kolon di Boston, MA

22 kajian untuk Kanser Kolon sedang mencari peserta di lokasi dalam dan sekitar Boston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Mengambil peserta
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

A Study of PHN-012 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • PHN-012-001 Site, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Mengambil pesertaFasa 3
  • Brigham and Women's Hospital (BWH), Boston
  • Dana-Farber Cancer Institute (DFCI), Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital - Main Campus, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07629960

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Mengambil pesertaFasa 3
  • Massachusetts General Hospital, Boston
  • Oncura Health, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07284849

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Mengambil peserta
  • Dana Farber Cancer Institute, Boston
Umur 18 hingga 50 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06202183

Resilience and Equity in Aging, Cancer, and Health (REACH)

Mengambil peserta
  • Dana-Farber Cancer Institute, Boston
Umur 65 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04674267

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Mengambil peserta
  • Massachusetts General Hospital Cancer Center, Boston
Umur 45 hingga 70 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Mengambil pesertaFasa 2/3
  • Tufts Medical Center, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05174169

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Mengambil pesertaKajian pemerhatian
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT07675967

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Mengambil pesertaFasa 1
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Mengambil pesertaFasa 1
  • Research Site, Boston
  • Research Site, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Mengambil pesertaFasa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital,, Boston
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Mengambil pesertaFasa 1/2
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Mei 2026 · NCT05379985

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Mengambil pesertaFasa awal 1
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT02172651

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Mengambil pesertaKajian pemerhatian
  • Dana Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Mei 2026 · NCT00843375

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Massachusetts General Hospital, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06239194

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Mengambil peserta
  • Dana-Farber Cancer Institute, Boston
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jan 2026 · NCT05773144

Building Connections

Mengambil peserta
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 18 Nov 2025 · NCT07091032

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Codman Square Health Center, Boston
  • East Boston Neighborhood Health Center, East Boston · 2 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT05524428

Kajian Kanser Kolon di bandar lain

Kajian lain di Boston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.